TG2 inhibitors and uses thereof

• 收藏
• 分享

专利权人:

Kapil Mehta

发明人:

Kapil Mehta,Anupam Kumar,Jansina Fok,Shuxing Zhang

申请号：

US13806257

公开号：

US08765797B2

申请日:

2011.06.21

申请国别(地区):

US

年份:

2014

代理人:

摘要：

Methods and compounds for treating cancer, dmg resistance and/or metastasis are described herein. These methods and compounds can inhibit the expression of aberrant TG2 expression and/or inhibit the binding of GTP to TG2, and thereby prevent the induction of epithelial to mesenchymal transition of cancer cells, and a stem cell-like phenotype.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/